Health Condition 1: N951- Menopausal and female climactericstates
Conditions
Interventions
Intervention1: Anisoon (Powdered/ Safoof form): Anisoon seed will be powdered and filled in 500mg capsule. Daily two capsules TDS orally will be given for 30 days.
Control Intervention1: Placebo (Roas
Sponsors
Luqman Unani Medical College Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: Women in the age group of 40-60 years having amenorrhea of at least 1 year with at least 5 episodes of hot flashes per day.
Exclusion criteria
Exclusion criteria: � H/o hormonal treatment or any other medications for treatment of hot flashes. � H/o malignancy or undiagnosed abnormal vaginal bleeding � H/o systemic and endocrinal diseases. � H/o hysterectomy, oophorectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the frequency and severity of hot flashes as per Daily Hot Flash DiaryTimepoint: 0th day (Baseline), 15th day, 30th day, post treatment follow up on 45th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Hot flash-Related Daily Interference Scale (HFRDIS)Timepoint: 0th day (Baseline), 15th day, 30th day, post treatment follow up on 45th day. | — |
Countries
India
Contacts
Public ContactDr Khalil Ahmed Hundgund
Luqman Unani Medical College Hospital and Research Centre
Outcome results
None listed